PortfoliosLab logoPortfoliosLab logo
TMED vs. XHS
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TMED vs. XHS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and SPDR S&P Health Care Services ETF (XHS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMED achieves a 15.07% return, which is significantly lower than XHS's 25.69% return.


TMED

1D
-1.51%
1M
7.82%
6M
12.95%
YTD
15.07%
1Y
36.59%
3Y*
5Y*
10Y*

XHS

1D
-0.59%
1M
9.97%
6M
23.02%
YTD
25.69%
1Y
41.48%
3Y*
13.17%
5Y*
4.22%
10Y*
9.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. XHS - Yearly Performance Comparison


2026 (YTD)2025
TMED
T. Rowe Price Health Care ETF
15.07%19.49%
XHS
SPDR S&P Health Care Services ETF
25.69%9.76%

Correlation

The correlation between TMED and XHS is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.58

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2025

0.58

The correlation between TMED and XHS has been stable across timeframes, ranging from 0.58 to 0.58 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMED vs. XHS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMED
TMED Risk / Return Rank: 7878
Overall Rank
TMED Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
TMED Sortino Ratio Rank: 8282
Sortino Ratio Rank
TMED Omega Ratio Rank: 7373
Omega Ratio Rank
TMED Calmar Ratio Rank: 7979
Calmar Ratio Rank
TMED Martin Ratio Rank: 7676
Martin Ratio Rank

XHS
XHS Risk / Return Rank: 8484
Overall Rank
XHS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
XHS Sortino Ratio Rank: 8787
Sortino Ratio Rank
XHS Omega Ratio Rank: 8585
Omega Ratio Rank
XHS Calmar Ratio Rank: 8282
Calmar Ratio Rank
XHS Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMED vs. XHS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and SPDR S&P Health Care Services ETF (XHS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMEDXHSDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-0.23

Omega ratioGain probability vs. loss probability

1.34

1.40

-0.06

Calmar ratioReturn relative to maximum drawdown

3.31

3.48

-0.17

Martin ratioReturn relative to average drawdown

11.19

11.98

-0.79

TMED vs. XHS - Sharpe Ratio Comparison

The current TMED Sharpe Ratio is 1.98, which is comparable to the XHS Sharpe Ratio of 2.31. The chart below compares the historical Sharpe Ratios of TMED and XHS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TMED vs. XHS - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum XHS drawdown of -39.32%. Use the drawdown chart below to compare losses from any high point for TMED and XHS.


Loading charts...

Drawdown Indicators


TMEDXHSDifference

Max Drawdown

Largest peak-to-trough decline

-11.11%

-39.32%

+28.21%

Max Drawdown (1Y)

Largest decline over 1 year

-11.11%

-11.99%

+0.88%

Max Drawdown (3Y)

Largest decline over 3 years

-17.81%

Max Drawdown (5Y)

Largest decline over 5 years

-31.34%

Max Drawdown (10Y)

Largest decline over 10 years

-39.32%

Current Drawdown

Current decline from peak

-3.34%

-2.56%

-0.78%

Average Drawdown

Average peak-to-trough decline

-2.39%

-10.13%

+7.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.31%

3.61%

-0.30%

Volatility

TMED vs. XHS - Volatility Comparison

The current volatility for T. Rowe Price Health Care ETF (TMED) is 5.12%, while SPDR S&P Health Care Services ETF (XHS) has a volatility of 5.43%. This indicates that TMED experiences smaller price fluctuations and is considered to be less risky than XHS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMEDXHSDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.12%

5.43%

-0.31%

Volatility (6M)

Calculated over the trailing 6-month period

14.15%

12.86%

+1.29%

Volatility (1Y)

Calculated over the trailing 1-year period

18.53%

18.04%

+0.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.22%

21.22%

-3.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.22%

22.41%

-4.19%

TMED vs. XHS - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is higher than XHS's 0.35% expense ratio.


Dividends

TMED vs. XHS - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.47%, more than XHS's 0.20% yield.


PositionTTM20252024202320222021202020192018201720162015
TMED
T. Rowe Price Health Care ETF
0.47%0.54%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XHS
SPDR S&P Health Care Services ETF
0.20%0.27%0.38%0.23%0.19%0.20%0.23%2.37%0.34%0.22%0.28%0.93%

Frequently Asked Questions


TMED and XHS have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XHS has higher volatility (5.43%) compared to TMED (5.12%). In terms of maximum drawdown, TMED dropped -11.11% vs XHS's -39.32%.

On 1-year performance, XHS leads with 41.48% vs 36.59% for TMED. On fees, XHS is cheaper at 0.35% per year. On volatility, TMED has been the lower-risk option at 5.12%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, XHS has performed better with a 41.48% return vs 36.59%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XHS is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.

TMED has the higher dividend yield at 0.47%, compared with 0.20% for XHS.

They also come from different issuers: T. Rowe Price and State Street. Their fees differ too: 0.44% for TMED and 0.35% for XHS.

XHS currently has the higher Sharpe Ratio (2.31 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMED and XHS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer